Literature DB >> 7144255

Rheumatic fever in Rochester, Minnesota, 1935-1978.

J F Annegers, N L Pillman, W H Weidman, L T Kurland.   

Abstract

The incidence of rheumatic fever in the population of Rochester, Minnesota, during the years 1935 through 1978 was determined by means of the medical records-linkage system of the Rochester Epidemiology Program Project. The annual age-adjusted incidence rate per 100,000 population for all episodes of rheumatic fever was 9.7, comprising 7.0 for initial attacks and 2.7 for recurrent attacks. There was a marked decline over time: incidence rates of initial episodes decreased from 13.6 in 1935-1949 to 8.2 in 1950-1964 and 2.7 in 1965-1978; and rates of recurrent attacks decreased even more--from 7.0 to 3.2 and 0.3 in the same intervals. There was also a secular trend in the clinical manifestations of rheumatic fever, as the proportion of initial episodes with carditis increased from 23% in 1935-44 to 52% in 1965-1978.

Entities:  

Mesh:

Year:  1982        PMID: 7144255

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

1.  Ethnic differences in mortality from acute rheumatic fever and chronic rheumatic heart disease in New Mexico, 1958-1982.

Authors:  T M Becker; C L Wiggins; C R Key; J M Samet
Journal:  West J Med       Date:  1989-01

Review 2.  Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa.

Authors:  Vuyisile T Nkomo
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

3.  Acute rheumatic fever in the young: changing prevalence and pattern.

Authors:  G Eshel; J Barr; E Azizi; M Aladgem; M Algom; G Mundel
Journal:  Eur J Pediatr       Date:  1988-12       Impact factor: 3.183

4.  The incidence of acute rheumatic fever in a suburban area of Los Angeles. A ten-year study.

Authors:  A Odio
Journal:  West J Med       Date:  1986-02

5.  The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease.

Authors:  Michael D Seckeler; Tracey R Hoke
Journal:  Clin Epidemiol       Date:  2011-02-22       Impact factor: 4.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.